Free Trial

Atara Biotherapeutics (ATRA) Insider Trading & Ownership

Atara Biotherapeutics logo
$9.80 0.00 (0.00%)
As of 05/22/2026 04:00 PM Eastern

Atara Biotherapeutics (NASDAQ:ATRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
41.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$856.84K
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$3.81M
Get ATRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Atara Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATRA Insider Buying and Selling by Quarter

Atara Biotherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/18/2026
Anhco Nguyen
CEO
Sell5,241$9.13$47,850.33  
5/18/2026
Yanina Grant-Huerta
CAO
Sell2,414$9.13$22,039.82  
5/7/2026
Innovation Ltd Panacea
Major Shareholder
Sell313,446$10.10$3,165,804.60  
1/12/2026
Innovation Ltd Panacea
Major Shareholder
Sell80,554$6.07$488,962.78  
11/17/2025
Anhco Nguyen
CEO
Sell2,915$13.19$38,448.85  
11/17/2025
Yanina Grant-Huerta
CAO
Sell1,804$13.19$23,794.76  
11/17/2025
Yanina Grant-Huerta
CAO
Sell1,804$13.19$23,794.76  
8/15/2025
Innovation Ltd Panacea
Major Shareholder
Buy55,000$12.19$670,450.00  
7/17/2025
Innovation Ltd Panacea
Major Shareholder
Buy19,335$9.64$186,389.40  
(Data available from 1/1/2013 forward)

ATRA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Atara Biotherapeutics includes Amar Murugan, Anhco Nguyen, Carol Giltner Gallagher, Eric J Hyllengren, Innovation Ltd Panacea, Jill Henrich, Pascal Touchon, William K Heiden, and Yanina Grant-Huerta. Learn more on insiders at ATRA.

41.20% of Atara Biotherapeutics stock is owned by insiders. Learn more on ATRA's insider holdings.

The following insider purchased ATRA shares in the last 24 months: Innovation Ltd Panacea ($856,839.40).

Insiders have purchased a total of 74,335 ATRA shares in the last 24 months for a total of $856,839.40 bought.

The following insiders have sold ATRA shares in the last 24 months: Anhco Nguyen ($162,471.97), Eric J Hyllengren ($30,847.90), Innovation Ltd Panacea ($3,654,767.38), Jill Henrich ($18,613.00), Pascal Touchon ($20,141.94), and Yanina Grant-Huerta ($84,623.02).

Insiders have sold a total of 429,230 Atara Biotherapeutics shares in the last 24 months for a total of $3,971,465.21 sold.



This page (NASDAQ:ATRA) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners